NARAYANA NETHRALAYA
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- -
- Established
- 1982-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
11
Active:0
Completed:2
Trial Phases
3 Phases
Phase 3:1
Phase 4:4
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 4
4 (57.1%)Not Applicable
1 (14.3%)phase_1_2
1 (14.3%)Phase 3
1 (14.3%)Comparison of Next Generation Laser Techniques of Myopia Correction: iDesign vs. SMILE
Phase 4
- Conditions
- Myopia
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2016-12-23
- Lead Sponsor
- Narayana Nethralaya
- Target Recruit Count
- 100
- Registration Number
- NCT03001401
- Locations
- 🇮🇳
Narayana Nethralaya, Bangalore, Karnataka, India
Identification and Validation of Functional Biomarkers for Keratoconus
- Conditions
- Keratoconus
- Interventions
- Drug: Cyclosporins
- First Posted Date
- 2012-12-11
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- Narayana Nethralaya
- Target Recruit Count
- 200
- Registration Number
- NCT01746823
- Locations
- 🇮🇳
Narayana Nethralaya, Bangalore, Karnataka, India
Intravitreal Bevacizumab for Retinal Disorders
Not Applicable
- Conditions
- Wet AMDMacular OedemaProliferative Diabetic Retinopathy
- First Posted Date
- 2006-11-23
- Last Posted Date
- 2006-11-23
- Lead Sponsor
- Narayana Nethralaya
- Target Recruit Count
- 150
- Registration Number
- NCT00403026
- Locations
- 🇮🇳
Sivakami Pai, Bangalore, India
News
No news found